HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.
6th Edition of Euro-Global Conference on Biotechnology and Bioengineering
September 28-30 | Hybrid Event
Antibody Biology and Engineering
Antibody Biology and Engineering
(5-1). Antibody Properties and Diversity
(5-2). New Approaches to Engineering Antibodies
(5-3). Immunoglobulin Effector Function
(5-4). Therapeutic Antibodies
(5-5). Antibody Cross-Talk
(5-6). Pre-Clinical Antibody Evaluation
Committee Members
Thomas J Webster
Brown University, United States
Babak Faramarzi
Western University of Health Sciences, United States
Julia Sidorova
Instituto Carlos III de Salud (CIBER-EHD), Spain ECBB 2026 Speakers
Zuchang Pei
Independent Researcher, Canada
Md Monir Hossain
RMIT University, Australia
Santosh Kumar Mishra
S.N.D.T. Women's University (Retired), India
Koustav Sarkar
SRM Institute of Science and Technology, IndiaSubmit your abstract Today
Title : Why do 90% of the drugs fail in development? An analysis of 82+ submissions; and a case study of immunotherapy
Narendra Chirmule, Indian Institute of Technology (IIT), India
Title : Eliminating implant failure in humans with nano chemistry: 45,000 cases and counting
Thomas J Webster, Brown University, United States
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Steps and strides: Cross-species insights into movement and injury
Babak Faramarzi, Western University of Health Sciences, United States
Title : Ancient wisdom, modern science: Biotech services transforming ayurveda
Prashant Sakharam Bhokardankar, Datta Meghe Ayurvedic Medical College Hospital and Research Centre, India
Title : Scientist’s computational lawyer
Julia Sidorova, Instituto Carlos III de Salud (CIBER-EHD), Spain